Hemofarm AD Farmaceutsko-hemijska industrija Vrsac 2022 Sustainability Report
Company: Hemofarm AD Farmaceutsko-hemijska industrija Vrsac
Sector: Manufacturing
Country: Serbia
Year: 2022
Type: Sustainability Report
Pages: 74
The report presents Hemofarm's 2022 sustainability performance through a first double-materiality assessment, a workforce of 4,086 Hemofarm Group employees, and detailed environmental resource and waste data. It reports 482,805 m3 of total water consumption and 1,350.714 t of industrial waste generated, alongside electricity, gas, and emissions disclosures. The report also documents ESG initiatives spanning employee development, health and safety, access to medicines, responsible procurement, and community health programs. Scope 1 and Scope 2 emissions are reported for Hemofarm and STADA Group, with a 42% Scope 1 and 2 reduction goal for 2030.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.